RNDr. Jitka Malčíková, Ph.D.

2018

• Biomarker-aided clinical decision making in CLL: conclusions from the workshops and future perspectives. Conclusions on Recurrent gene mutations

  MALČÍKOVÁ Jitka SUTTON LA.

  Year: 2018, type:

• ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation

  MALČÍKOVÁ Jitka TAUSCH E. ROSSI D. SUTTON L.A. SOUSSI T. ZENZ T. KATER A.P. NIEMANN C.U. GONZALEZ D. DAVI F. DIAZ M.G. MORENO C. GAIDANO G. STAMATOPOULOS K. ROSENQUIST R. STILGENBAUER S. GHIA P. POSPÍŠILOVÁ Šárka

  Article in Periodical

  Leukemia, year: 2018, volume: 32, edition: 5, DOI

• Evolution of genomic abnormalities during CLL disease course is associated with telomere length changes

  OLBERTOVÁ Helena PLEVOVÁ Karla MALČÍKOVÁ Jitka KOTAŠKOVÁ Jana PAVLOVÁ Šárka ŠPUNAROVÁ Michaela TRBUŠEK Martin NAVRKALOVÁ Veronika KANTOROVÁ Barbara BRYCHTOVÁ Yvona PANOVSKÁ Anna DOUBEK Michael POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2018, type: Conference abstract

• Evolution of genomic abnormalities during leukemia disease course is associated with telomere length changes

  OLBERTOVÁ Helena PLEVOVÁ Karla MALČÍKOVÁ Jitka PAVLOVÁ Šárka POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2018, type: Conference abstract

• Genetic aberrations and progression-free survival in CLL patients treated with front line rituximab-based chemoimmunotherapy (FCR/BR): clinical practice experience

  ŠPUNAROVÁ Michaela MALČÍKOVÁ Jitka TOM Nikola BORSKÝ Marek BRYCHTOVÁ Yvona DOUBEK Michael PANOVSKÁ Anna SKUHROVÁ FRANCOVÁ Hana ĎURECHOVÁ Kristina BRZOBOHATÁ A. FREIBERGEROVÁ Anna JAROŠOVÁ Marie MRÁZ Marek POSPÍŠILOVÁ Šárka MAYER Jiří TRBUŠEK Martin

  Conference abstract

  Year: 2018, type: Conference abstract

• Hands on workshops on clinically relevant biomarkers: Cell-intrinsic biomarkers – Recurrent gene mutations: TP53 and beyond

  MALČÍKOVÁ Jitka SUTTON LA.

  Year: 2018, type:

• Changes in telomere length associate with to evolution of genomic abnormalities during CLL disease course

  OLBERTOVÁ Helena PLEVOVÁ Karla MALČÍKOVÁ Jitka PAVLOVÁ Šárka NAVRKALOVÁ Veronika BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2018, type: Conference abstract

• Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status

  KUBEŠOVÁ Blanka PAVLOVÁ Šárka MALČÍKOVÁ Jitka KABÁTHOVÁ Jitka RADOVÁ Lenka TOM Nikola TICHÝ Boris PLEVOVÁ Karla KANTOROVÁ Barbara FIEDOROVÁ Kristýna SLAVIKOVA M. BYSTRÝ Vojtěch KISSOVÁ Jarmila GISSLINGER B. GISSLINGER H. PENKA Miroslav MAYER Jiří KRALOVICS R. POSPÍŠILOVÁ Šárka DOUBEK Michael

  Article in Periodical

  Leukemia, year: 2018, volume: 32, edition: 2, DOI

• Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL

  BRÁZDILOVÁ Kamila PLEVOVÁ Karla SKUHROVÁ FRANCOVÁ Hana OLBERTOVÁ Helena BORSKÝ Marek BIKOS Vasileios MALČÍKOVÁ Jitka OLTOVÁ Alexandra KOTAŠKOVÁ Jana TICHÝ Boris BRYCHTOVÁ Yvona MAYER Jiří DOUBEK Michael POSPÍŠILOVÁ Šárka

  Article in Periodical

  Leukemia, year: 2018, volume: 32, edition: 1, DOI

• Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing

  TIKKANEN T. LEROY B. FOURNIER J.L. RISQUES R.A. MALČÍKOVÁ Jitka SOUSSI T.

  Article in Periodical

  Human Mutation, year: 2018, volume: 39, edition: 7, DOI